Position in GILD
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$224,000
-$22,545 QoQ
Shares Held
1,773
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,854
of 2,266 holders
Holding Since
Jun 2023
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COURIER CAPITAL LLC holds $42,194,870 across 11 Drug Manufacturers - General names. GILD ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
64,486 | $16,377,509 | |
| 2 | MRK |
Merck & Co., Inc.
|
53,603 | $6,887,985 | |
| 3 | LLY |
ELI LILLY & Co
|
4,669 | $5,600,139 | |
| 4 | AMGN |
Amgen Inc
|
12,257 | $4,438,504 | |
| 5 | ABBV |
AbbVie Inc.
|
15,875 | $3,994,785 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
35,523 | $2,046,835 | |
| 7 | AZN |
Astrazeneca PLC
|
5,104 | $967,820 | |
| 8 | PFE |
Pfizer Inc
|
39,040 | $940,083 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $224,000 | 1,773 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $246,545 | 1,769 | Shares | Sole | 2026-04-23 | |
| 2024-03-31 | $656,686 | 8,965 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $734,355 | 9,065 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $691,696 | 9,230 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $713,436 | 9,257 | Shares | Sole | 2023-07-31 | |
| No filing history on record for this holder in this stock. | ||||||